YLR467C-A Antibody

What is YLR467C-A antibody and what is its specific target?

YLR467C-A antibody is a polyclonal antibody raised in rabbits that specifically targets the YLR467C-A protein in Saccharomyces cerevisiae (strain ATCC 204508/S288c), commonly known as Baker's yeast. This antibody is developed using recombinant YLR467C-A protein as the immunogen to ensure specific targeting of the native protein. As a polyclonal preparation, it contains a heterogeneous mixture of antibodies that recognize different epitopes on the target protein, providing robust detection capabilities across multiple applications .

The target protein, YLR467C-A, is encoded by the YLR467C-A gene in S. cerevisiae and has been assigned the UniProt accession number P0CL39. While the search results don't detail the specific biological function of this protein, the development of a specific antibody indicates its significance in yeast biology research contexts.

What are the critical storage and handling considerations for YLR467C-A antibody?

Proper storage and handling of YLR467C-A antibody is essential for maintaining its functionality and specificity. The antibody is provided in liquid form with a storage buffer containing 50% glycerol, 0.01M PBS (pH 7.4), and 0.03% Proclin 300 as a preservative. For optimal long-term stability, the antibody should be stored at either -20°C or -80°C immediately upon receipt .

Repeated freeze-thaw cycles should be strictly avoided as they can lead to antibody denaturation, aggregation, and loss of binding capacity. Research practices suggest aliquoting the antibody into smaller volumes upon first thaw to minimize freeze-thaw cycles. When handling the antibody, researchers should maintain sterile conditions and use appropriate laboratory techniques to prevent contamination.

What validated applications exist for YLR467C-A antibody in yeast research?

YLR467C-A antibody has been specifically validated for two primary applications in yeast research:

• Enzyme-Linked Immunosorbent Assay (ELISA): This application allows for quantitative detection of YLR467C-A protein in solution-phase samples. The antibody can be used as either a capture or detection antibody in sandwich ELISA configurations, depending on the experimental design requirements .

• Western Blotting (WB): The antibody is validated for detection of denatured YLR467C-A protein separated by SDS-PAGE and transferred to a membrane support. This application is particularly useful for determining protein expression levels, molecular weight verification, and comparative analysis across experimental conditions .

How should researchers determine the optimal working dilution for YLR467C-A antibody?

Determining the optimal working dilution for YLR467C-A antibody requires systematic titration experiments tailored to each application. While specific recommended dilutions aren't provided in the search results, standard approaches for polyclonal antibodies can be applied:

For Western blotting applications:

• Prepare a dilution series (e.g., 1:500, 1:1000, 1:2000, 1:5000) of the antibody

• Run identical protein samples on multiple blots or use a multi-channel apparatus

• Process each blot with a different antibody dilution while keeping all other conditions constant

• Compare signal-to-noise ratios across dilutions

• Select the dilution that provides the strongest specific signal with minimal background

For ELISA applications:

• Perform a checkerboard titration with varying concentrations of both coating antigen and antibody

• Create a matrix with antigen dilutions on one axis and antibody dilutions on the other

• Calculate signal-to-noise ratios for each combination

• Identify the optimal working range where specific signal is maximized and background is minimized

These optimization experiments should include appropriate positive and negative controls to ensure reliability of results.

What are the most effective methods for reducing non-specific binding when using YLR467C-A antibody?

Non-specific binding can significantly impact experimental results when working with YLR467C-A antibody. Several methodological approaches can minimize this issue:

• Optimize blocking conditions: Test different blocking agents (BSA, non-fat dry milk, commercial blocking solutions) at various concentrations and incubation times. For yeast proteins, 5% BSA or specialized yeast-optimized blockers may be more effective than milk-based blockers.

• Increase wash stringency: Incorporate additional wash steps and/or increase the concentration of detergents (e.g., Tween-20, up to 0.1%) in wash buffers. Consider using Triton X-100 (0.1-0.3%) for more stringent washing.

• Pre-absorb antibody: Incubate the diluted antibody with proteins from non-expressing yeast strains or with other relevant blocking proteins to remove antibodies that might bind non-specifically.

• Titrate primary antibody: Reduce the concentration of YLR467C-A antibody to the minimum effective dose that still produces specific signal, as higher concentrations often correlate with increased background.

• Optimize incubation conditions: Conduct antibody incubations at 4°C overnight rather than at room temperature to improve specificity of binding interactions.

These techniques can be systematically tested and combined to develop an optimized protocol specific to the research application.

How can researchers validate the specificity of YLR467C-A antibody in their experimental system?

Validating antibody specificity is crucial for ensuring reliable research findings. For YLR467C-A antibody, researchers should employ multiple complementary approaches:

• Genetic validation: Use YLR467C-A knockout or deletion strains of S. cerevisiae as negative controls. The absence of signal in these samples strongly supports antibody specificity.

• Epitope competition: Pre-incubate the antibody with excess recombinant YLR467C-A protein or the immunizing peptide. Reduction or elimination of signal indicates specific binding.

• Orthogonal detection methods: Compare results with alternative detection techniques such as mass spectrometry or with a second antibody recognizing a different epitope on the same protein.

• Molecular weight verification: Confirm that the detected protein band in Western blotting appears at the expected molecular weight for YLR467C-A.

• Correlation with expression systems: Demonstrate signal intensity changes in systems where YLR467C-A is experimentally overexpressed or downregulated.

Thorough validation not only confirms antibody specificity but also strengthens the credibility of subsequent research findings.

What methodological approaches can be used to study protein-protein interactions involving YLR467C-A?

Investigating protein-protein interactions involving YLR467C-A requires specialized techniques that leverage the specificity of YLR467C-A antibody:

• Co-immunoprecipitation (Co-IP): Use YLR467C-A antibody to pull down the target protein along with its interaction partners. This approach works best with gentle lysis conditions that preserve native protein complexes. The precipitated material can be analyzed by mass spectrometry or Western blotting for known or suspected interaction partners.

• Proximity ligation assay (PLA): This technique can detect protein interactions in situ with high sensitivity. It requires YLR467C-A antibody and antibodies against suspected interaction partners, followed by oligonucleotide-conjugated secondary antibodies that generate fluorescent signals when proteins are in close proximity.

• Chromatin immunoprecipitation (ChIP): If YLR467C-A is suspected to interact with DNA or chromatin-associated proteins, ChIP using YLR467C-A antibody can identify genomic binding sites or chromatin-associated interaction partners.

• Bimolecular fluorescence complementation (BiFC): While not directly using the antibody, this complementary approach involves tagging YLR467C-A and potential partners with fragments of fluorescent proteins that reconstitute fluorescence when brought together by protein interaction.

Each of these methods provides different insights into protein interactions and may be selected based on specific research questions and available resources.

How can YLR467C-A antibody be utilized for subcellular localization studies in yeast?

YLR467C-A antibody can be employed for precise subcellular localization studies through several methodological approaches:

• Immunofluorescence microscopy: This technique requires:

  • Fixation of yeast cells (typically with formaldehyde)

  • Cell wall digestion with zymolyase to increase permeability

  • Permeabilization with detergents like Triton X-100

  • Blocking with appropriate agents

  • Incubation with YLR467C-A antibody followed by fluorophore-conjugated secondary antibodies

  • Co-staining with organelle markers for reference

• Immunoelectron microscopy: For ultra-high resolution localization, YLR467C-A antibody can be used with gold-conjugated secondary antibodies for transmission electron microscopy imaging. This approach requires specialized sample preparation but provides nanometer-scale resolution.

• Subcellular fractionation with immunoblotting: This biochemical approach involves:

  • Fractionating yeast cells into distinct subcellular compartments

  • Preparing protein samples from each fraction

  • Performing Western blotting with YLR467C-A antibody

  • Using markers for different organelles to confirm fractionation quality

These approaches can be used complementarily to provide comprehensive information about YLR467C-A localization under different physiological conditions or genetic backgrounds.

What are the best practices for quantitative analysis of Western blot data using YLR467C-A antibody?

Rigorous quantitative analysis of Western blot data generated with YLR467C-A antibody requires several methodological considerations:

How should researchers address discrepancies between results obtained with YLR467C-A antibody and other detection methods?

When faced with discrepancies between YLR467C-A antibody results and other detection methods, researchers should employ a systematic troubleshooting approach:

• Verify antibody specificity: Revisit antibody validation experiments to confirm the specificity of YLR467C-A antibody in the specific experimental context.

• Consider protein modifications: Post-translational modifications may affect antibody recognition without altering detection by other methods. Analyze whether experimental conditions might induce modifications to YLR467C-A protein.

• Evaluate protein conformation effects: Different detection methods may access different protein conformations. The YLR467C-A antibody may recognize epitopes that are masked or exposed depending on protein folding state.

• Assess method sensitivity differences: Compare detection limits between methods. Some techniques may be more sensitive than antibody-based detection for proteins expressed at low levels.

• Examine extraction or preparation efficiency: Different sample preparation methods may variably extract or preserve YLR467C-A protein, leading to apparent discrepancies between detection methods.

• Design orthogonal validation experiments: Develop experiments specifically designed to address the nature of the discrepancy, such as epitope mapping, detection limit determination, or modification-specific analyses.

When reporting discrepancies in research publications, transparent documentation of all methodological details is essential to facilitate interpretation by the scientific community.